inulin
Drug data last refreshed 8h ago · AI intelligence enriched 3w ago
Inulin and Sodium Chloride is an injectable diagnostic agent approved in 1940, used primarily for renal function assessment and glomerular filtration rate (GFR) measurement. The product contains inulin, a polysaccharide that is freely filtered by the kidneys and not reabsorbed, making it a gold-standard marker for kidney function evaluation.
This legacy injectable diagnostic product faces declining market relevance as modern alternatives gain adoption, suggesting limited team expansion and focus on managed transition strategies.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
The Effects of Oral Fructanase Administration on Gastrointestinal Symptoms After Inulin Challenge in Healthy Adults
Impact of Native Chicory Inulin on Change and Persistence of Gut Microbiota
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
Safety and Tolerability Trial of Microbial Inulinase
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on this legacy diagnostic product offers limited career growth and job openings (0 linked positions), as the product is approaching loss of exclusivity and faces structural market headwinds. Roles available are primarily defensive—focused on market maintenance, compliance, and managed decline rather than expansion or innovation.